Europe Non-Opioid Pain Patches Market Size & Outlook
The non-opioid pain patches market in Europe is expected to reach a projected revenue of US$ 467.1 million by 2033. A compound annual growth rate of 4.92% is expected of Europe non-opioid pain patches market from 2026 to 2033.
Revenue, 2025 (US$M)
$312.1
Estimate, 2026 (US$M)
$333.7
Forecast, 2033 (US$M)
$467.1
CAGR, 2026 - 2033
4.9%
Global Market
Related Markets
Europe non-opioid pain patches market highlights
- The Europe non-opioid pain patches market generated a revenue of USD 312.1 million in 2025.
- The market is expected to grow at a CAGR of 4.92% from 2026 to 2033.
- In terms of segment, lidocaine patches was the largest revenue generating type in 2025.
- Capsaicin Patches is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 312.1 million |
| Market revenue in 2033 | USD 467.1 million |
| Growth rate | 4.92% (CAGR from 2026 to 2033) |
| Largest segment | Lidocaine patches |
| Fastest growing segment | Capsaicin Patches |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Capsaicin Patches, Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Ketoprofen Patches |
| Key market players worldwide | Teva Pharmaceutical Industries Ltd, GSK PLC ADR, Hisamitsu Pharmaceutical Co Inc, Alkermes PLC, Teikoku Pharma, Mylan, Acorda Therapeutics, IBSA |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.6% of the global non-opioid pain patches market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 381.9 million by 2033.
No credit card required*
Publish Date: Jul 03, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Non-Opioid Pain Patches Market Scope
Non-opioid Pain Patches Market segmentation & scope
Others
Non-Opioid Pain Patches Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| GSK PLC ADR | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| Hisamitsu Pharmaceutical Co Inc | View profile | 3,682 | 408 Tashiro Daikan-machi, Tosu, Saga, Japan, 841-0017 | www.hisamitsu.co.jp |
| Alkermes PLC | View profile | 2,100 | 1 Burlington Road, Connaught House, Dublin, Ireland, D04 C5Y6 | www.alkermes.com |
| Mylan | View profile | 10001+ | - | www.mylan.in/ |
| Teikoku Pharma | View profile | 51-100 | San Jose, California, United States, North America | www.teikokuusa.com/ |
| IBSA | View profile | 11-50 | Abbotsford, New South Wales, Australia, Oceania | www.ibsa.com.au/ |
| Acorda Therapeutics | View profile | 251-500 | Hawthorne, New York, United States, North America | www.acorda.com/ |
Europe Non-opioid Pain Patches Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Non-opioid Pain Patches Market Outlook will help companies and investors design strategic landscapes.
Lidocaine Patches was the largest segment with a revenue share of 37.42% in 2025.
Horizon Databook has segmented the Europe non-opioid pain patches market based on capsaicin patches, lidocaine patches, diclofenac patches, methyl salicylate patches, ketoprofen patches covering the revenue growth of each sub-segment from 2021 to 2033.
- Europe Non-Opioid Pain Patches Market Type Outlook (Revenue, USD Million , 2021-2033)
- Lidocaine Patches
- Diclofenac Patches
- Methyl Salicylate Patches
- Capsaicin Patches
- Ketoprofen Patches
- Others
- Europe Non-Opioid Pain Patches Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Others
Reasons to subscribe to Non-opioid Pain Patches Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Non-opioid Pain Patches Market Outlook databook
- Our clientele includes a mix of Non-opioid Pain Patches Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Non-opioid Pain Patches Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Non-opioid Pain Patches Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Non-Opioid Pain Patches Market, 2021-2033 (US$M)
Europe Type - Non-opioid Pain Patches Market Statistics, 2025 - 2033 (US$M)
